> I don't think that's true at all. I seem to remember several studies. I linked the FDA announcement for the latest dosing changes. You can see how they justi

> I don't think that's true at all. I seem to remember several studies. I linked the FDA announcement for the latest dosing changes. You can see how they justify it. It's funny that you link the CovBoost thing. They're summarizing this paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02717-3/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6... Which is not about the bivalent vaccines (it's from 2021, concerning dose 3, not...6? 7?), and it's by this fellow, who...let's just say that he's not taking your side of the argument: https://twitter.com/apsmunro/status/1466707690332340227 https://twitter.com/apsmunro/status/1466707690332340227 It's a good paper, it just doesn't support the argument you're making. Overall, it shows that third dose boosting seems to play a minimal role in otherwise healthy people who have had two doses and been infected.